INTRODUCTION
============

Retinal detachment repair procedures can be followed by non-resolution of Subretinal Fluid (SRF), especially when the surgical procedure doesn't involve internal or external drainage of SRF \[[@B1], [@B2]\]. Desatnik et al. identified the incidence of delayed SRF absorption in seven (4.3%) out of 160 patients, who underwent pneumatic retinopexy \[[@B3]\]. The complete resolution of SRF can take up to several months or even years \[[@B3], [@B4]\]. Some authors found that the presence of postoperative SRF might delay visual recovery, however, it did not seem to influence final visual outcome \[[@B1], [@B5]\]. Other authors demonstrated that persistent SRF might impose a detrimental effect on photoreceptors by delaying visual recovery and by causing structural changes in photoreceptors, resulting in poorer visual prognosis and worse visual outcome after the complete resolution of SRF \[[@B4], [@B6]-[@B9]\]. It is believed that persistent SRF should be managed conservatively by observation \[3\], however, other therapeutic approaches \[[@B10]-[@B12]\] that have been proposed in the literature in order to expedite the resolution of SRF, through both safety and efficacy, remain unclear. Conventional laser treatment has been attempted in the past yet it did not seem to achieve immediate results \[[@B3], [@B13]\]. Subthreshold Micropulse Laser (MPL) was found safe and effective in many macular diseases, especially when used for successful absorption of SRF in chronic Central Serous Retinopathy (CSR), by inducing a biological response on Retinal Pigment Epithelium (RPE) cells, which promotes recovery and restoration of the outer blood-retinal barrier and accelerates the resolution of the SRF \[[@B14]-[@B19]\]. Subthreshold MPL produces therapeutic effects that appear comparable to those of conventional laser with no detectable signs of laser-induced iatrogenic damage \[[@B20]\]. The purpose of this manuscript was to report the outcome of MPL application for persistent SRF in a patient, who had been previously treated for retinal detachment.

MATERIALS AND METHODS
=====================

The case was a 41-year-old male, who initially presented complaints of blurry vision and nasal visual field defect in the left eye. The symptoms started two weeks prior to his referral. His ocular, systemic, and family histories were unremarkable, except for mild myopia. On presentation, Corrected Distance Visual Acuity (CDVA) was 20/40. The rest of anterior segment exams were within normal limits. On fundus examination, there was evidence of macula-splitting superior Rhegmatogenous Retinal Detachment (RRD), involving superonasal, superotemporal, and inferotemporal quadrants with two adjacent superior retinal breaks and area of lattice with no holes, inferiorly. Spectral Domain Optical Coherence Tomography (SD-OCT) (Cirrus 5000, Carl Zeiss Meditec Inc., Dublin, CA, USA) demonstrated SRF sub-foveally and central foveal retinal thickness of 553 microns. The patient underwent retinal pneumopexy with injection of 0.5 cc of undiluted C3F8 (perfluoropropane) gas. Retina was flattened and laser retinopexy was performed around retinal breaks and lattice. Corrected distance visual acuity improved to 20/30-. However, the SRF under the fovea was persistently observed on his repeated retinal exams. The patient maintained face-down positioning with no improvement in SRF, even after additional pneumopexy (0.5 cc undiluted C3F8) and laser retinopexy (360 degrees of laser barrage was completed), which were repeated after one month. Although his visual acuity remained stable at 20/30, the patient reported visual disturbance during each visit. During the follow-up, it was noted that persistent sub-macular fluid had been gradually building up, yet repeated meticulous exams of retinal periphery under scleral depression on each visit showed no evidence of retinal defects. The treatment options, which included repeated pneumopexy, vitrectomy or buckle, were discussed with the patient on multiple occasions and the patient insistently refused any surgical intervention, despite unremitting subjective complaints of blurry vision in this eye. Increase in the amount of SRF was correlated with increase of blurry vision complaints during the follow-up. Subthreshold micropulse laser was offered to the patient. Since no subsequent head positioning was required and no intravitreal gas injection, preventing patient's frequent travels, was needed, the patient expressed his willingness to undergo the procedure and gave informed consent, understanding the risks. Fourteen months after the initial pneumopexy, subthreshold MPL (577 nm yellow laser, Iridex IQ 577™, Mountain View, CA, USA) was successfully applied to cover the entire area of the SRF, using established parameters (200 micrometer spot diameter, 0.20 second duration, 10% duty cycle, 200 miliwatt power, 9 grids of 7x7 pattern, and total of 441 spots). Ethical issues were completely observed by the author.

RESULTS
=======

The improvement in SRF and clinical symptoms were started two weeks later and the SRF had resolved within four months after the application of MPL. Corrected distance visual acuity improved from 20/30 to 20/20, accompanied by marked improvement in blurriness. The patient was followed up for three years and no recurrence of SRF was noted. Longitudinal change in central foveal thickness during the follow-up and serial SD-OCT scans are presented in [Fig 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.

DISCUSSION
==========

The present case report described a case of successful resolution of persistent SRF, achieved after subthreshold MPL application in a patient, who had been previously treated for RRD. The presence of SRF after successful RD repair is a common finding, especially when evaluated by OCT, and can detect subclinical submacular fluid, persisting for months without being recognized on ophthalmoscopy \[[@B5], [@B21], [@B22]\]. Sub-retinal fluid is believed to resolve spontaneously in the majority of cases \[[@B3], [@B10], [@B21]\]. However, there is evidence that apoptosis of photoreceptors occurs in chronic RD, suggesting that the longer SRF will be present under the fovea, and the worse functional visual outcome might be achieved \[[@B23]\]. Micropulse laser has been reported to be effective in resolution of SRF in multiple retinal conditions, especially in patients with chronic CSR \[[@B14], [@B15]\]. It has been hypothesized that RPE disturbance plays an important role in the pathogenesis of persistent SRF formation, and stimulation of RPE's pumping function may help in SRF absorption, without causing structural and permanent damage to retinal tissue \[[@B16]\].
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The decision of performing MPL in the presented patient was commanded by gradual accumulation of SRF and deterioration of patient's subjective visual complaints while driving, working in front of the computer, reading, and performing other essential daily activities. Shortly after the MPL application, both subjective improvement (marked decrease in visual disturbance) and objective improvement (CDVA improved from 20/30 to 20/20) were observed. It may be speculated that visual improvement in this case was caused by a natural resolution of SRF, since the resolution of SRF may be as lengthy as two years. Nevertheless, the clinical course and dynamics of central foveal thickness changes, which showed gradual deterioration during the follow-up, were reversed by MPL. Micropulse laser treatment served a turning point for clinical improvement, leading to complete SRF resolution within several months, following the MPL application. Patient's vision remained stable and no recurrence of SRF was observed for three years after the MPL application.

CONCLUSIONS
===========

The use of micropulse laser for treatment of persistent SRF following a RD procedure resulted in complete resolution of the fluid and retinal reattachment. Further research is necessary to confirm the efficacy, safety, and consistency of MPL in achieving complete resolution of SRF in post-retinal detachment repair patients with persistent SRF.
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